Matches 1 - 50 out of 67 1 2 >


Match Document Document Title
US20150064261 Multiparticulate L-Menthol Formulations and Related Methods  
A multiparticulate dosage form includes a plurality of individual spheroidal enteric coated particulates having (a) a diameter of 0.1 to 2.5 mm; (b) a solid core containing an effective amount of...
US20140030348 DOSAGE FORMS FOR ORAL ADMINISTRATION AND METHODS OF TREATMENT USING THE SAME  
The invention relates to dosage forms that provide prolonged therapy. In particular, the invention relates to dosage forms including various pluralities of drug-containing resin particles. The...
US20110165256 COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPLASIA  
In accordance with the present invention, there are provided methods for treating hyperplasia in a subject in need thereof. In another aspect of the invention, there are provided methods for...
US20150050352 Enteric Coated Multiparticulate Composition With Proteinaceous Subcoat  
A multiparticulate composition includes a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and having a continuous proteinaceous subcoating...
US20150044294 Enteric Coated Multiparticulate Composition With Proteinaceous Subcoat  
A multiparticulate composition includes a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and having a continuous proteinaceous subcoating...
US20140314860 ENTERIC COATED MULTIPARTICULATE COMPOSITION WITH PROTEINACEOUS SUBCOAT  
A multiparticulate composition includes a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and having a continuous proteinaceous subcoating...
US20130039990 INJECTABLE, LOAD-BEARING CELL/MICROBEAD/CALCIUM PHOSPHATE BONE PASTE FOR BONE TISSUE ENGINEERING  
The invention provides injectable, stem cell-containing calcium phosphate bone pastes for bone tissue engineering and methods of making and using the same.
US20110206771 Encapsulated functional fine particle composition capable of spraying and preparation method thereof  
Provided is an encapsulated functional fine particle composition capable of spraying that is useful for hemostasis and wound protection and allows a patient to treat the wound by oneself....
US20140017324 MULTIPARTICULATE L-MENTHOL FORMULATIONS AND RELATED METHODS  
An L-menthol-containing multiparticulate formulation includes a plurality of individual enteric coated cores containing L-menthol from an at least 80% pure L-menthol source. The enteric coated...
US20070264326 Anti-misuse oral microparticle medicinal formulation  
The field of the present invention is that of solid microparticulate analgesic oral medicines. The invention is that of providing novel analgesic medicines which allow at the same time the...
US20120315336 INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS  
Described are injectable formulations of particulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable...
US20100221330 BUOYANT FORMULATIONS OF BETAINE  
An oral control release formulation for releasing at least one betaine after oral administration to a human, said formulation comprising at least one pharmaceutically acceptable means ensuring an...
US20130189366 DRUG DELIVERY SYSTEMS AND METHODS OF USE  
Disclosed herein are systems for delivery of one or more molecules (such as a drug, for example, a small molecule, polypeptide, and/or nucleic acid) to a subject, for example to a targeted...
US20140093576 Pharmaceutical Dosage Form with Multiple Coatings for Reduced Impact of Coating Fractures  
The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a...
US20150056291 Adhesive Containing Microparticles  
Methods for forming and incorporating microparticles containing one or more active agents into adhesives are described. The methods involve spray drying a liquid of the one or more active agents...
US20140170224 GELATIN-BASED MICROGELS  
A gelatin-based microgel was prepared by a simple method starting from gelatin and alginate. The microgel was composed of a soft gelatin-based core coated by a permeable membrane. Gelatin-based...
US20120021058 PROCESS FOR MAKING DRY AND STABLE HEMOSTATIC COMPOSITIONS  
Described is a process for making a dry and stable hemostatic composition, said process comprising a) providing a dry granular preparation of a biocompatible polymer suitable for use in...
US20120076864 Microcapsules Containing Microorganisms  
Microcapsules for delivery of a liquid onto a surface such as a hard surface or a textile, such as mattress ticking, are disclosed. The microcapsules have a shell with an outer face and an inner...
US20130101673 COMPOSITIONS AND THEIR USE IN BONE HEALING  
The present invention is directed to implantable compositions comprising substantially spherical bioactive glass particles.
US20140356440 Enteric Coated Multiparticulate Controlled Release Peppermint Oil Composition and Related Methods  
A multiparticulate composition is formed from a plurality of individual cores including a hydrophobic phase containing peppermint oil dispersed in a microcrystalline cellulose-based gel and a...
US20140017325 ENTERIC COATED MULTIPARTICULATE CONTROLLED RELEASE PEPPERMINT OIL COMPOSITION AND RELATED METHODS  
A multiparticulate composition is formed from a plurality of individual cores including a hydrophobic phase containing peppermint oil dispersed in a microcrystalline cellulose-based gel and a...
US20120040008 PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS  
Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active...
US20120148677 CONTROLLED RELEASE PARTICLES CONTAINING ACID FIBROBLAST GROWTH FACTOR  
Disclosed herein is a controlled release particle comprising a therapeutically effective amount of acid fibroblast growth factor (aFGF), entrapped by a particle composed by a biocompatible anionic...
US20120128780 NANOPARTICULATE BISPHOSPHONATE COMPOSITIONS  
Nanoparticulate bisphosphonate compositions, having an effective average particle size of less than 2000 nm, are described. The compositions are useful in treating bone resorption in a mammal.
US20100266705 NANOPARTICULATE MEGESTROL FORMULATIONS  
The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
US20050226936 Method of soft tissue augmentation  
Particles according to the invention are made of a viscoelastic medium, are injectable gel particles, and have a size, when subjected to a physiological salt solution, in the range of from 1 to 5...
US20120076863 NANOPARTICULATE STABILIZED ANTI-HYPERTENSIVE COMPOSITIONS  
The present invention is directed to anti-hypertensive compositions comprising a nanoparticulate temocapril, or a salt or derivative thereof, having improved bioavailability. The nanoparticulate...
US20100260842 PSEUDOEPHEDRINE PHARMACEUTICAL FORMULATIONS  
Controlled-release pharmaceutical formulations comprising pseudoephedrine or any of its pharmaceutically acceptable salts, processes for preparing the pharmaceutical formulations, and methods of...
US20100166871 VERMIN POISON  
Use of an orally or nasally available formulation of Tretazicar for poisoning vermin. An orally available or nasally available formulation of Tretazicar, wherein in the orally available...
US20100173002 Microcapsules with improved shells  
Disclosed are microcapsules and methods for preparing and using them, as well as methods for improving various properties of microcapsules like impermeability.
US20130309313 Compositions and Methods for Increasing the Stability of Food Product Additives  
Disclosed are compositions including powdered green tea extract and a powdered preparation comprising polyunsaturated fatty acids. Also disclosed are methods of preparing the compositions and...
US20080318788 Microcapsule  
A microcapsule comprising an active component encapsulated therein, and comprising a particulate matter located in a wall thereof to render the wall permeable. Such microcapsules can be used in a...
US20100209519 PHARMACEUTICAL COMPOSITION FOR INHALATION DELIVERY AND FABRICATION METHOD THEREOF  
A pharmaceutical composition for inhalation delivery is provided, including drugs and a gelatin nanoparticle encapsulating the drugs to form a drug-gelatin nanocomplex, wherein the surface of the...
US20140044793 MICROENCAPSULATION PROCESS AND PRODUCT  
A composition comprising a core material, having a taste value and a polymeric coating. The polymeric coating substantially surrounds the core material and comprises a cationic polymer and...
US20080253961 Formulation of Active Agent Loaded Activated PLGA Nanoparticles for Targeted Cancer Nano-Therapeutics  
The present invention includes compositions and methods of making an activated polymeric nanoparticle for targeted drug delivery that includes a biocompatible polymer and an amphiphilic...
US20080260843 TRANSPULMONARY COMPOSITION  
It is an object of the present invention to provide a transpulmonary preparation wherein physiologically active ingredient can be stably retained and which has high absorption efficacy and gives...
US20140255502 NANOPARTICLE DRUG CARRIER, PHARMACEUTICAL COMPOSITION AND MANUFACTURING METHOD THEREOF  
A pharmaceutical composition is provided. The pharmaceutical composition includes a nanoparticle, a shell and a drug, wherein the nanoparticle has an outer surface and the drug is mixed with the...
US20140348934 ROTARY DIE SYSTEM  
A rotary die system that includes first and second axially aligned, coacting rotary dies positioned adjacent one another. Each die includes a working surface having a plurality of recesses defined...
US20110256229 RAPID-ACTING PHARMACEUTICAL COMPOSITION  
A pharmaceutical composition for the treatment of acute disorders is described. The composition comprises an essentially water-free, ordered mixture of at least one pharmaceutically active agent...
US20100233276 COMPOSITIONS IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND OF A TWO-COMPONENTS EXCIPIENT, AND PROCESS FOR THEIR PREPARATION  
The described agglomeration of drug microparticles blended with excipient microparticles is a technique for the size enlargement of micronized products that could be damaged by granulation or...
US20110236494 CIPROFLOXACIN ORAL SUSPENSION  
The present invention relates to oral taste masked pharmaceutical composition comprising ciprofloxacin or salts or esters thereof. It further relates to processes of preparing it.
US20120015038 ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF  
The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release...
US20100260858 DRUG DELIVERY COMPOSITION  
A composition for delivery of a drug is disclosed. The composition has a semipermeable coating, particles of a medicament having an effective average particle size of less than or about 2 μm and...
US20140105993 MODIFIED-RELEASE MICROPARTICLES BASED ON AMPHIPHILIC COPOLYMER AND ON ACTIVE PRINCIPLE(S) AND PHARMACEUTICAL FORMULATIONS COMPRISING THEM  
The present invention relates to novel microparticles formed of amphiphilic polyamino acids which transport active principle(s), AP(s), in particular protein and peptide active principle(s), and...
US20080063725 Prolonged-release multimicroparticulate oral pharmaceutical form  
Modified-release multimicroparticulate pharmaceutical form capable of maintaining the modified release of the active principle in an alcoholic solution and of resisting attempts at misuse.
US20080206316 Chromium-Fatty Acid Compounds and Methods of Making and Using Thereof  
Disclosed are compounds comprising one or more chromium atoms bonded to one or more fatty acids. Also disclosed are nutritional supplements, pharmaceutical formulations, delivery devices, and...
US20150175704 ANTI-NR10 ANTIBODY AND USE THEREOF  
The present inventors successfully obtained anti-NR10 antibodies having an effective neutralizing activity against NR10. The anti-NR10 antibodies provided by the present invention are useful as,...
US20050282763 Methods of treating bladder disorders  
Methods of treating bladder disorders, including bladder cancer and inflammatory bladder diseases such as interstitial cystitis are disclosed. The methods include identifying a mammal that has or...
US20100209498 PHARMACEUTICAL COMPOSITIONS OF DULOXETINE  
The present invention relates to pharmaceutical compositions of duloxetine or pharmaceutically acceptable salts thereof, and processes for their preparation.
US20130084340 Compositions and Methods of Making Sustained Release Liquid Formulations  
The present invention includes compositions and methods for the controlled release of active agents in a shelf-stable liquid formulation by blending one or more controlled release microbeads...

Matches 1 - 50 out of 67 1 2 >